Correlation Between Syndax Pharmaceuticals and Cogent Biosciences
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Cogent Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Cogent Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Cogent Biosciences, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Cogent Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Cogent Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Cogent Biosciences.
Diversification Opportunities for Syndax Pharmaceuticals and Cogent Biosciences
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Syndax and Cogent is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Cogent Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cogent Biosciences and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Cogent Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cogent Biosciences has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Cogent Biosciences go up and down completely randomly.
Pair Corralation between Syndax Pharmaceuticals and Cogent Biosciences
Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 1.44 times less return on investment than Cogent Biosciences. But when comparing it to its historical volatility, Syndax Pharmaceuticals is 1.0 times less risky than Cogent Biosciences. It trades about 0.04 of its potential returns per unit of risk. Cogent Biosciences is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 780.00 in Cogent Biosciences on October 20, 2024 and sell it today you would earn a total of 23.00 from holding Cogent Biosciences or generate 2.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Syndax Pharmaceuticals vs. Cogent Biosciences
Performance |
| Timeline |
| Syndax Pharmaceuticals |
| Cogent Biosciences |
Syndax Pharmaceuticals and Cogent Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Syndax Pharmaceuticals and Cogent Biosciences
The main advantage of trading using opposite Syndax Pharmaceuticals and Cogent Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Cogent Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cogent Biosciences will offset losses from the drop in Cogent Biosciences' long position.| Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
| Cogent Biosciences vs. Larimar Therapeutics | Cogent Biosciences vs. Kura Oncology | Cogent Biosciences vs. Kiniksa Pharmaceuticals | Cogent Biosciences vs. Ideaya Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |